Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML 2022-08-17 04:05
1